Dashboard
Manage Tickers

PFE PFIZER INC

NYSE pfizer.com


$ 24.53 $ -0.27 (-1.09 %)    

Tuesday, 28-Oct-2025 18:20:34 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 633.54 $ 4.83 (0.77 %)
DIA $ 477.21 $ 1.80 (0.38 %)
SPY $ 687.37 $ 1.82 (0.27 %)
TLT $ 92.12 $ 0.24 (0.26 %)
GLD $ 361.57 $ -2.63 (-0.72 %)
$ 24.5
$ 24.76
$ 24.52 x 41
$ 24.53 x 1,100
$ 24.38 - $ 24.78
$ 20.18 - $ 27.69
49,956,579
na
139.3B
$ 0.52
$ 12.96
TBD
na
na ($ 0.07)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-29-2025 10-Q
2 05-05-2025 03-30-2025 10-Q
3 02-27-2025 12-31-2024 10-K
4 11-04-2024 09-29-2024 10-Q
5 08-05-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 11-08-2023 10-01-2023 10-Q
9 08-09-2023 07-02-2023 10-Q
10 05-10-2023 04-02-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-09-2022 10-02-2022 10-Q
13 08-10-2022 07-03-2022 10-Q
14 05-11-2022 04-03-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-12-2021 10-03-2021 10-Q
17 08-12-2021 07-04-2021 10-Q
18 05-13-2021 04-04-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-05-2020 09-27-2020 10-Q
21 08-06-2020 06-28-2020 10-Q
22 05-07-2020 03-29-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 11-07-2019 09-29-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-09-2018 07-01-2018 10-Q
30 05-10-2018 04-01-2018 10-Q
31 02-22-2018 12-31-2017 10-K
32 11-09-2017 10-01-2017 10-Q
33 08-10-2017 07-02-2017 10-Q
34 05-11-2017 04-02-2017 10-Q
35 02-23-2017 12-31-2016 10-K
36 11-10-2016 10-02-2016 10-Q
37 08-11-2016 07-03-2016 10-Q
38 05-12-2016 04-03-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-05-2015 09-27-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ken-paxton-alleges-johnson--johnson-misled-mothers-on-tylenol-safety
Ken Paxton Alleges Johnson & Johnson Misle...
10/28/2025 17:11:17

Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for ...

Core News & Articles
'US Fires Top Health Official Who Opposed ...
10/28/2025 12:50:58

https://www.bloomberg.com/news/articles/2025-10-28/us-fires-top-health-official-who-opposed-widely-used-covid-shots?srnd=homepa...

wellgistics-and-datavault-team-up-to-transform-prescription-tracking
Wellgistics And DataVault Team Up To Trans...
10/22/2025 12:30:33

DataVault AI and Wellgistics Health are collaborating to bring blockchain technology to the US prescription drug market.

pfizer-canada-announces-health-canada-approval-of-abrysvo-for-adults-18-health-canada-approved-new-indication-for-abrysvo-for-use-in-adults-aged-18-59
Pfizer Canada Announces Health Canada Appr...
10/21/2025 16:04:56

With the approval of ABRYSVO® for adults aged 18+, there is now a way to help protect against RSV in a population that previous...

mark-cuban-isnt-convinced-trumprx-is-going-to-change-the-game-but-hes-giving-them-credit-for-trying
Mark Cuban Isn't Convinced TrumpRx Is Goin...
10/21/2025 05:38:41

Billionaire entrepreneur Mark Cuban offered rare praise for the Trump administration's push to lower prescription drug cost...

reported-sunday-pfizers-braftovi-plus-mektovi-delivers-476-month-median-overall-survival-in-treatment-nave-braf-v600e-mutant-lung-cancer-setting-new-long-term-benchmark
Reported Sunday, Pfizer's BRAFTOVI Plus ME...
10/20/2025 07:44:05

BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients w...

Core News & Articles
Reported Sunday, Pfizer And Astellas Repor...
10/20/2025 07:41:36

The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in ...

invo-fertility-stock-is-plunging-after-white-house-announcement
Invo Fertility Stock Is Plunging After Whi...
10/17/2025 18:37:05

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House announceme...

uk-health-agency-recommends-gsk-backed-viiv-healthcares-apretude-as-injectable-hiv-treatment
UK Health Agency Recommends GSK-Backed Vii...
10/17/2025 16:43:32

NICE recommends ViiV Healthcare's Apretude as the first injectable PrEP for HIV prevention, offering an alternative to dail...

novo-vs-lilly-vs-pfizer-who-wins-if-trump-slashes-the-price-of-weight-loss-drugs
Novo Vs. Lilly Vs. Pfizer: Who Wins If Tru...
10/17/2025 14:19:58

Trump's promise to cut cost of Novo Nordisk A/S drug Ozempic from $1,300 to $150 shakes GLP-1 gold rush, with potential imp...

reported-earlier-pfizer-ceo-says-us-pharma-industry-needs-to-collaborate-with-china--reuters
Reported Earlier: 'Pfizer CEO says US phar...
10/15/2025 11:43:40

https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-ceo-says-us-pharma-industry-needs-collaborate-with-china-202...

wall-streets-most-accurate-analysts-spotlight-on-3-health-care-stocks-with-over-3-dividend-yields
Wall Street's Most Accurate Analysts Spotl...
10/15/2025 11:15:13

pfizer-seeks-expanded-use-approval-for-breast-cancer-drug
Pfizer Seeks Expanded Use Approval For Bre...
10/14/2025 17:37:12

Pfizer's Tukysa improved progression-free survival in first-line HER2+ metastatic breast cancer, showing strong efficacy an...

hedge-fund-shah-capital-urges-novavax-to-consider-sale-amid-vaccine-rollout-struggles-sees-5-billion-potential
Hedge Fund Shah Capital Urges Novavax To C...
10/14/2025 17:08:17

Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least...

pfizer-announces-topline-results-from-phase-3-her2climb-05-trial-of-first-line-combination-therapy-with-tyrosine-kinase-inhibitor-tukysa-in-patients-with-her2-mbc
Pfizer Announces Topline Results From Phas...
10/14/2025 10:46:49

Pfizer Inc. (NYSE:PFE) today announced positive topline results from the Phase 3 HER2CLIMB-05 trial of first-line combination t...

Core News & Articles
Arvinas And Pfizer To Highlight New Vepdeg...
10/13/2025 11:08:29

Presentation to include new patient-reported outcomes (PRO) data from the Phase 3 VERITAC-2 clinical trial 

pfizer-to-present-46-infectious-disease-abstracts-at-idweek-2025-congress-highlighting-advancements-in-prevention-and-treatment
Pfizer To Present 46 Infectious Disease Ab...
10/13/2025 10:47:25

Pfizer Inc. (NYSE:PFE, "Pfizer"))) will present data across its infectious disease portfolio at the upcoming IDWeek 202...

Core News & Articles
President Trump Announces Achievement On D...
10/10/2025 21:37:40

https://www.youtube.com/watch?v=XOtOCzut9pM

trump-plans-astrazeneca-deal-to-cut-drug-prices-for-low-income-americans
Trump Plans AstraZeneca Deal To Cut Drug P...
10/10/2025 18:48:27

Trump to announce new deal with AstraZeneca to lower prescription drug costs for Americans using most-favored-nation pricing mo...

morgan-stanley-maintains-equal-weight-on-pfizer-lowers-price-target-to-32
Morgan Stanley Maintains Equal-Weight on P...
10/10/2025 17:42:29

Morgan Stanley analyst Terence Flynn maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $33 to...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION